Analysis of the off-licence use of recombinant activated factor VII for patients with uncontrolled haemorrhage in a UK tertiary referral hospital

por Spivey, M, Eve, H, Duffy, M
Publicado 2009

Implementation of Traffic Light System on food sold at Brockfield House Medium secure unit to help improve healthy food options

por Agunwamba, N., Ho, D., Duffy, M.
Publicado 2022

Comparison between Urine Protein: Creatinine Ratios of Samples Obtained from Dogs in Home and Hospital Settings

por Duffy, M.E., Specht, A., Hill, R.C.
Publicado 2015

Trends in vitamin D supplement use in a general female and breast cancer population in Ireland: A repeated cross-sectional study

por Madden, J. M., Duffy, M. J., Zgaga, L., Bennett, K.
Publicado 2018

International Meeting on Physical Interpretations of Relativity Theory

por Duffy, M C, Gladyshev, V O, Morozov, A N, Rowlands, P
Publicado 2005

Evaluation of assays for thyroxine, triodotyronine and thyroid-stimulating hormone on the ARIA II automated radioimmunoassay instrument

por Duffy, M. J., Tuttlebee, J., O'Sullivan, F., Allen-Davis, M.
Publicado 1983

Plasma concentrations of the platelet-specific beta-thromboglobulin in malignant disease.

por Farrell, R. J., Duffy, M. J., Moriarty, M. J., Duffy, G. J.
Publicado 1980

Hypercalcaemia resulting from the use of tigecycline in the treatment of multidrug-resistant Acinetobacter in patients with multiorgan failure

por Duffy, M, Thomas, M, Auzinger, G, Bernal, W, Sizer, E, Wendon, J
Publicado 2007

Fibrinogen as a prognostic indicator in hepatic failure

por Thomas, M, Duffy, M, Auzinger, G, Bernal, W, Sizer, E, Wendon, J
Publicado 2007

The relevance of coagulation factor X protection of adenoviruses in human sera

por Duffy, M R, Doszpoly, A, Turner, G, Nicklin, S A, Baker, A H
Publicado 2016

Serum sialic acid and CEA concentrations in human breast cancer.

por Hogan-Ryan, A., Fennelly, J. J., Jones, M., Cantwell, B., Duffy, M. J.
Publicado 1980

Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistry.

por Kennedy, S., Duffy, M. J., Duggan, C., Barnes, C., Rafferty, R., Kramer, M. D.
Publicado 1998

Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.

por Duffy, M. J., Blaser, J., Duggan, C., McDermott, E., O'Higgins, N., Fennelly, J. J., Tschesche, H.
Publicado 1995

Plasminogen activator inhibitor type 2 in breast cancer.

por Duggan, C., Kennedy, S., Kramer, M. D., Barnes, C., Elvin, P., McDermott, E., O'Higgins, N., Duffy, M. J.
Publicado 1997

Overexpression of the Ets-1 transcription factor in human breast cancer

por Buggy, Y, Maguire, T M, McGreal, G, McDermott, E, Hill, A D K, O'Higgins, N, Duffy, M J
Publicado 2004

Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.

por Remacle, A. G., Noël, A., Duggan, C., McDermott, E., O'Higgins, N., Foidart, J. M., Duffy, M. J.
Publicado 1998

Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer

por Ryan, B, O'Donovan, N, Browne, B, O'Shea, C, Crown, J, Hill, A D K, McDermott, E, O'Higgins, N, Duffy, M J
Publicado 2005

Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells

por Caiazza, F, McGowan, P M, Mullooly, M, Murray, A, Synnott, N, O'Donovan, N, Flanagan, L, Tape, C J, Murphy, G, Crown, J, Duffy, M J
Publicado 2015

Elevated expression and altered processing of fibulin-1 protein in human breast cancer

por Greene, L M, Twal, W O, Duffy, M J, McDermott, E W, Hill, A D, O'Higgins, N J, McCann, A H, Dervan, P A, Argraves, W S, Gallagher, W M
Publicado 2003

Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA

por McKiernan, E, O'Brien, K, Grebenchtchikov, N, Geurts-Moespot, A, Sieuwerts, A M, Martens, J W M, Magdolen, V, Evoy, D, McDermott, E, Crown, J, Sweep, F C G J, Duffy, M J
Publicado 2008